Literature DB >> 16694269

THE RESISTANCE TO FIBRINOLYTIC ACTIVITY OF THE HEMOLYTIC STREPTOCOCCUS WITH SPECIAL REFERENCE TO PATIENTS WITH RHEUMATIC FEVER AND RHEUMATOID (ATROPHIC) ARTHRITIS.

W K Myers1, C S Keefer, W F Holmes.   

Abstract

Entities:  

Year:  1935        PMID： 16694269      PMCID： PMC424663          DOI： 10.1172/JCI100646

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  ANTISTREPTOLYSIN CONTENT OF THE BLOOD SERUM IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS.

Authors:  W K Myers; C S Keefer
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

2.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

3.  STREPTOCOCCAL AGGLUTININS IN PATIENTS WITH RHEUMATOID (ATROPHIC) ARTHRITIS AND ACUTE RHEUMATIC FEVER.

Authors:  C S Keefer; W K Myers; T W Oppel
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

4.  SKIN REACTIONS TO NUCLEOPROTEIN OF STREPTOCOCCUS SCARLATINAE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RHEUMATIC FEVER.

Authors:  W K Myers; C S Keefer; T W Oppel
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808
  4 in total
  10 in total

1.  The relationship between acute rheumatism and streptococcal antifibrinolysin.

Authors:  C B Perry
Journal:  Arch Dis Child       Date:  1939-03       Impact factor: 3.791

2.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett
Journal:  Bacteriol Rev       Date:  1938-12

3.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

4.  THE IN VITRO AND IN VIVO EFFECT OF SULFONAMIDES UPON THE STREPTOCOCCAL ANTIFIBRINOLYSIN TEST.

Authors:  W M Kirby; L A Rantz
Journal:  J Clin Invest       Date:  1942-05       Impact factor: 14.808

5.  STUDIES ON THE IMMUNE RESPONSE OF THE RHEUMATIC SUBJECT AND ITS RELATIONSHIP TO ACTIVITY OF THE RHEUMATIC PROCESS. IV. CHARACTERISTICS OF STRAINS OF HEMOLYTIC STREPTOCOCCUS, EFFECTIVE AND NON-EFFECTIVE IN INITIATING RHEUMATIC ACTIVITY.

Authors:  A F Coburn; R H Pauli
Journal:  J Clin Invest       Date:  1935-11       Impact factor: 14.808

6.  THE STREPTOCOCCAL ANTIFIBRINOLYSIN TEST IN CLINICAL USE.

Authors:  P L Boisvert
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

7.  STUDIES OF HEMOLYTIC STREPTOCOCCAL INFECTION II. THE SEROLOGICAL REACTIONS OF THE BLOOD DURING ERYSIPELAS.

Authors:  W W Spink; C S Keefer
Journal:  J Clin Invest       Date:  1936-01       Impact factor: 14.808

8.  DEVELOPMENT OF ANTIFIBRINOLYTIC PROPERTIES IN BLOOD OF PATIENTS WITH RHEUMATIC FEVER, CHRONIC INFECTIVE ARTHRITIS AND BACTERIAL ENDOCARDITIS.

Authors:  E Waaler
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

9.  QUANTITATIVE ANTISTREPTOKINASE STUDIES IN PATIENTS INFECTED WITH GROUP A HEMOLYTIC STREPTOCOCCI: A COMPARISON WITH SERUM ANTISTREPTOLYSIN AND GAMMA GLOBULIN LEVELS WITH SPECIAL REFERENCE TO THE OCCURRENCE OF RHEUMATIC FEVER.

Authors:  H C Anderson; H G Kunkel; M McCarty
Journal:  J Clin Invest       Date:  1948-07       Impact factor: 14.808

10.  Streptococcal Antifibrinolysin in Rheumatoid Arthritis and Spondylitis Ankylopoietica.

Authors:  C B Perry
Journal:  Ann Rheum Dis       Date:  1940-12       Impact factor: 19.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.